期刊文献+

外周血GPC3与PEG10 mRNA检测对肝细胞癌转移的诊断价值 被引量:3

Value of GPC3 and PEG10 mRNA in peripheral blood in diagnosis of metastasis in hepatocellular carcinoma
下载PDF
导出
摘要 目的研究外周血磷脂酰肌醇蛋白聚糖3(GPC-3)与遗传印迹基因(PEG10)mRNA检测对肝细胞癌(HCC)转移的诊断价值。方法30例HCC患者分为HCC转移组(n=18)和HCC未转移组(n=12),另选取11例肝硬化患者作为对照。以SYBRGreenⅠ作为荧光信号,采用实时荧光定量聚合酶链反应(FQ RT-PCR)检测三组患者外周血GPC-3 mRNA和PEG10 mRNA表达,应用ROC曲线和诊断性能专用指标评价两者预测诊断及排除诊断的价值。结果HCC转移组GPC-3 mRNA和PEG10 mRNA表达显著高于HCC未转移组和肝硬化组(P<0.05);HCC未转移组与肝硬化组GPC-3 mRNA和PEG10 mRNA的表达比较差异无统计学意义。单项检测GPC-3 mRNA和PEG10 mRNA的诊断灵敏度分别为66.7%和72.2%,特异度均为91.7%,ROC曲线下面积(AUC)为0.748和0.812;两基因检测平行试验的灵敏度为90.7%,特异度为84.0%,阴性似然比为0.11,诊断准确率为83.3%;系列试验的灵敏度为60.5%,特异度为98.7%,阳性似然比为45.5,诊断准确率为73.3%。结论检测外周血GPC-3mRNA和PEG10 mRNA对估计肝癌有无血行播散和肝外转移有一定的价值,且PEG10 mRNA优于GPC-3 mRNA。两者联合系列试验有助于HCC外周血转移的预测诊断。 Objective To explore the value of glypican-3 (GPC-3) mRNA and paternally expressed 10 (PEG10) mRNA in peripheral blood in diagnosis of metastasis in hepatocellular carcinoma (HCC). Methods With SYBR Green I as fluorescence signal, real-time fluorescent quantitative reverse transcription-polymerase chain reaction was employed to detect the expression of GPC-3 mRNA and PEG10 mRNA in peripheral blood from patients with HCC with metastasis (n = 8), HCC without metastasis (n = 12) and hepatic cirrhosis (n = 11), and receiver operator characteristics curve (ROC) and specific parameters were adopted to analyse their value in predictive and exclusive diagnosis. Results The expression of GPG-3 mRNA and PEG10 mRNA in HCC with metastasis was significantly higher than that in HCC without metastasis and in hepatic cirrhosis (P 〈 0.05), while there was no significant difference in the expression of GPC-3 mRNA and PEG10 mRNA between HCC without metastasis and hepatic cirrhosis. In single test, the sensitivities in the differential diagnosis between HCC with metastasis and HCC without metastasis were 66.7% for GPC-3 mRNA and 72.2% for PEG10 mRNA, and the specifieities were 91.7% and 91.7%, respectively. The areas under ROC were 0. 748 for GPC-3 mRNA and 0. 812 for PEG10 mRNA. With two markers in parallel test, the sensitivity, specificity, negative likelihood and diagnostic accuracy were 90.7%, 84.0%, 0.11 and 83.3%, respectively. In serial test, the sensitivity, specificity, positive likelihood and diagnostic accuracy were 60.5%, 98.7%, 45.5 and 73.3%, respectively. Conclusion Detection of GPC-3 mRNA and PEG10 mRNA in peripheral blood may help to predict blood metastasis and extrahepatic metastasis of HCC, and PEG10 mRNA works better than GPC-3 mRNA. The serial test of GPC-3 mRNA and PEG10 mRNA is helpful to the predictive diagnosis of peripheral blood metastasis of HCC.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2010年第2期208-212,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市科委基金(06ZR14063)~~
关键词 肝细胞癌 转移 磷脂酰肌醇蛋白聚糖3基因 遗传印迹基因 ROC曲线 联合检测 hepatocellular carcinoma metastasis glypican-3 gene paternally expressed gene 10 ROC curve combined test
  • 相关文献

参考文献13

  • 1Livak KJ, Schmiltgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 ( -Delta Delta Ct) Method [J]. Methods, 2001, 25(4) : 402 -408.
  • 2Nakatsura T, Yoshitake Y, Senju S, et al. Glypieau-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker[J]. Biochem Biophys Res Commun, 2003, 306( 1 ) : 16 - 25.
  • 3Capurru M, Wanless IR, Sherman M, et al. Glypican-3 : a novel serum and histochemical marker for hepatocellular carcinoma [J].Gastroenterology, 2003,125( 1 ) : 89 -97.
  • 4Hippo Y, Watanabe K, Watanabe A, et al. Identification of soluble NH2-terminal fragment of glypiean-3 as a serological marker for early-stage hepatocellular carcinoma[ J]. Cancer Res, 2004, 64 (7) : 2418 - 2423.
  • 5Hsu HC, Cheng W, Lai PL. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution [J]. Cancer Rcs, 1997, 57(22) : 5179 -5184.
  • 6Zhu ZW, Friess H, Wang L, et al. Enhanced glypiean-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders[J]. Gut, 2001, 48(4) : 558 -564.
  • 7Ono R, Kobayashi S, Wagatsuma H, et al. A retrotransposon-derived gene, PEG10, is a novel imprinted gene located on human chromosome 7q21 [J]. Genomics, 2001, 73(2): 232-237.
  • 8Noble A, Towne C, Chopin L, et al. Insulin-like growth factor-Ⅱ bound to vitronectin enhances MCF-7 breast cancer cell migration [ J ]. Endocrinology, 2003,144 (6) : 2417 - 2424.
  • 9Moorehead RA, Sanchez OH, Baldwin RM, et al. Transgenlc overexpression of IGF-Ⅱ induces spontaneous lung tumors: a model for human lung adenocarcinoma[J]. Oncogene, 2003, 22(6) : 853 - 857.
  • 10Vella V, Sciacca L, Pandini G, et al. The IGF system in thyroid cancer:new concepts[J]. Mol Pathol, 2001, 54(3): 121 -124.

二级参考文献8

共引文献24

同被引文献26

  • 1张琼,叶达伟,常莹,宋宇虎,谢娜,王晓燕,林菊生.PEG10基因在不同转移潜能肝癌细胞中表达的定量分析[J].华中科技大学学报(医学版),2006,35(6):758-760. 被引量:11
  • 2常莹,陶璐薇,陈孝平,周秀敏,宋宇虎,黄锦,张琼,林菊生.肝癌组织中遗传印记基因PEG10表达的特异性及其意义[J].世界华人消化杂志,2005,13(12):1408-1411. 被引量:27
  • 3朱光辉,邬善敏,胡洪生.PEG10和c-MYC基因在肝细胞肝癌中的表达及意义[J].中华实验外科杂志,2006,23(8):1017-1017. 被引量:5
  • 4Ono R, Kobayashi S, Wagatsuma H, et al. A retro-trans-poson-derived gene,PEGlO,is a novel imprinted gene 10-cated on human chromosome 7q21 [J]. Genomics, 2001, 73(2) :232-237.
  • 5Tsou AP,Chuang YC, Su JY, et al. Overexpression of a novel imprinted gene, PEGI,in human hepatocellular carcinoma and in regenerating mouse livers[J]. Biomed Sci, 2003,10(8) :625-635.
  • 6Okabe H,Satoh S, Kate T, et al. Genome-wide analysis of gene expression in human hepatoceliular carcinomas using eDNA microarray:identification of genes involved in viral carcinogenesis and tumor progression[J]. Cancer Res, 2001,61(21) :2129-2137.
  • 7Lux A, Beil C, Majety M, et al. Human retroviral gag- and gag-pol like proteins interact with the transforming growth factor- β receptor activin receptor-like kinase 1[J].Biol Chem,2004,280(30) :8482 8493.
  • 8Li CM, Margolin AA, Salas M, et al. PEG10 is a c-MYC target gene in cancer cells[J]. Cancer Res, 2006,66 (2) : 665-672.
  • 9Ip WK,Lai PB,Wong NL, et al. Identifictaion of PEG10 as a progression related biomarker for hepatocellular carcinoma [J]. Cancer Lett, 2006,10 (10) : 1012-1016.
  • 10Okabe H,Satoh S, Furukawa Y, et al. Involvement of PEG10 in human hepatocellular carcinoma genesis through interaction with SIAHI[J].Cancer Res, 2003,63 (23) : 3043-3048.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部